These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20104506)

  • 1. An index of fatal toxicity for drugs of misuse.
    King LA; Corkery JM
    Hum Psychopharmacol; 2010 Mar; 25(2):162-6. PubMed ID: 20104506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between availability of heroin and methadone and fatal poisoning in England and Wales 1993-2004.
    Morgan O; Griffiths C; Hickman M
    Int J Epidemiol; 2006 Dec; 35(6):1579-85. PubMed ID: 17077102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-positive illicit-drug findings: implications for cause-of-death certification, classification and coding.
    Lahti RA; Korpi H; Vuori E
    Forensic Sci Int; 2009 May; 187(1-3):14-8. PubMed ID: 19303228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An index of fatal toxicity for new psychoactive substances.
    King LA; Corkery JM
    J Psychopharmacol; 2018 Jul; 32(7):793-801. PubMed ID: 29482434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality attributed to misuse of psychoactive drugs, 1979-88.
    Wysowski DK; Schober SE; Wise RP; Kopstein A
    Public Health Rep; 1993; 108(5):565-70. PubMed ID: 8416115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug use and perceived treatment need among newly sentenced prisoners in England and Wales.
    Stewart D
    Addiction; 2009 Feb; 104(2):243-7. PubMed ID: 19149820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment.
    Arendt M; Munk-Jørgensen P; Sher L; Jensen SO
    Drug Alcohol Depend; 2011 Apr; 114(2-3):134-9. PubMed ID: 20971585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a sustained heroin shortage in three Australian States.
    Degenhardt L; Day C; Dietze P; Pointer S; Conroy E; Collins L; Hall W
    Addiction; 2005 Jul; 100(7):908-20. PubMed ID: 15954999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002.
    Schifano F; Oyefeso A; Corkery J; Cobain K; Jambert-Gray R; Martinotti G; Ghodse AH
    Hum Psychopharmacol; 2003 Oct; 18(7):519-24. PubMed ID: 14533133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of 'visible' and 'invisible' users of amphetamine, cocaine and heroin: two distinct populations?
    Robson P; Bruce M
    Addiction; 1997 Dec; 92(12):1729-36. PubMed ID: 9581005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do Australian news media depict illicit drug issues? An analysis of print media reporting across and between illicit drugs, 2003-2008.
    Hughes CE; Lancaster K; Spicer B
    Int J Drug Policy; 2011 Jul; 22(4):285-91. PubMed ID: 21700441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age differentials in the impacts of reduced heroin: effects of a "heroin shortage" in NSW, Australia.
    Degenhardt L; Day C; Conroy E; Gilmour S; Hall W
    Drug Alcohol Depend; 2005 Sep; 79(3):397-404. PubMed ID: 15927418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying adolescent drug users: results of a national survey on adolescent health in Switzerland.
    Konings E; Dubois-Arber F; Narring F; Michaud PA
    J Adolesc Health; 1995 Mar; 16(3):240-7. PubMed ID: 7779836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High mortality rates among GHB abusers in Western Sweden.
    Knudsen K; Greter J; Verdicchio M
    Clin Toxicol (Phila); 2008 Mar; 46(3):187-92. PubMed ID: 18344100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Narcotics and illicit drug market. Status and 10-year development].
    Lindholst C; Andreasen MF; Kaa E
    Ugeskr Laeger; 2008 Jan; 170(1):54-7. PubMed ID: 18208718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of drug use during imprisonment: relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine and amphetamine in prison.
    Strang J; Gossop M; Heuston J; Green J; Whiteley C; Maden A
    Addiction; 2006 Aug; 101(8):1125-32. PubMed ID: 16869842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Student's use of illicit drugs: a survey in a preventive health service].
    Morvan Y; Rouvier J; Olié JP; Lôo H; Krebs MO
    Encephale; 2009 Dec; 35 Suppl 6():S202-8. PubMed ID: 20141772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes to the daily pattern of methadone-related deaths in England and Wales, 1993-2003.
    Morgan OW; Johnson H; Rooney C; Seagroatt V; Griffiths C
    J Public Health (Oxf); 2006 Dec; 28(4):318-23. PubMed ID: 17060353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.